Donna Peace

516 total citations
9 papers, 406 citations indexed

About

Donna Peace is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Donna Peace has authored 9 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Immunology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Donna Peace's work include Cardiovascular Function and Risk Factors (4 papers), Immunotherapy and Immune Responses (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Donna Peace is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Immunotherapy and Immune Responses (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Donna Peace collaborates with scholars based in United States and Poland. Donna Peace's co-authors include June P. Tow, Robert A. Zivin, Linda K. Jolliffe, Jeffrey A. Bluestone, Julie Auger, Danlin Xu, Stephen J. Kopp, D. J. Paulson, Thomas P. Haverty and E. Steve Woodle and has published in prestigious journals such as Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Research.

In The Last Decade

Donna Peace

9 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Peace United States 8 166 120 83 82 70 9 406
Cornelia Keller Switzerland 4 124 0.7× 110 0.9× 24 0.3× 19 0.2× 64 0.9× 4 406
McManus Bm United States 10 37 0.2× 19 0.2× 90 1.1× 29 0.4× 135 1.9× 20 321
Marja‐Liisa Solin Finland 10 58 0.3× 72 0.6× 9 0.1× 34 0.4× 26 0.4× 13 392
Klára Farkas Hungary 9 93 0.6× 130 1.1× 31 0.4× 10 0.1× 94 1.3× 26 316
Masahiko Kutsukake Japan 12 75 0.5× 46 0.4× 29 0.3× 9 0.1× 34 0.5× 17 334
B. W. Kirkham Australia 11 135 0.8× 19 0.2× 46 0.6× 33 0.4× 39 0.6× 16 487
Nemanja Zdravković Serbia 10 238 1.4× 27 0.2× 26 0.3× 28 0.3× 78 1.1× 21 405
U. Würzburg Germany 7 48 0.3× 27 0.2× 81 1.0× 69 0.8× 33 0.5× 10 297
Iris Cardolini Italy 8 186 1.1× 125 1.0× 73 0.9× 5 0.1× 58 0.8× 8 441
Shunsuke Ohori United States 10 150 0.9× 17 0.1× 34 0.4× 10 0.1× 72 1.0× 16 313

Countries citing papers authored by Donna Peace

Since Specialization
Citations

This map shows the geographic impact of Donna Peace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Peace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Peace more than expected).

Fields of papers citing papers by Donna Peace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Peace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Peace. The network helps show where Donna Peace may publish in the future.

Co-authorship network of co-authors of Donna Peace

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Peace. A scholar is included among the top collaborators of Donna Peace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Peace. Donna Peace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Utset, Tammy O., Julie Auger, Donna Peace, et al.. (2002). Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.. PubMed. 29(9). 1907–13. 98 indexed citations
2.
Woodle, E. Steve, Danlin Xu, Robert A. Zivin, et al.. (1999). PHASE I TRIAL OF A HUMANIZED, Fc RECEPTOR NONBINDING OKT3 ANTIBODY, huOKT3??1 (Ala-Ala) IN THE TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION. Transplantation. 68(5). 608–616. 140 indexed citations
3.
Richards, Jon, Julie Auger, Donna Peace, et al.. (1999). Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.. PubMed. 59(9). 2096–101. 35 indexed citations
4.
Loss, G., Hani P. Grewal, Christopher Siegel, et al.. (1998). Reversal of Delayed Hyperacute Renal Allograft Rejection With a Tacrolimus-Based Therapeutic Regimen. Transplantation Proceedings. 30(4). 1249–1250. 7 indexed citations
5.
Paulson, D. J., Stephen J. Kopp, Donna Peace, & June P. Tow. (1988). Improved postischemic recovery of cardiac pump function in exercised trained diabetic rats. Journal of Applied Physiology. 65(1). 187–193. 42 indexed citations
6.
Heller, Birgit, et al.. (1988). Depressed in vivo myocardial reactivity to dobutamine in streptozotocin diabetic rats: influence of exercise training. Cardiovascular Research. 22(6). 417–424. 17 indexed citations
7.
Paulson, D. J., Stephen J. Kopp, Donna Peace, & June P. Tow. (1987). Myocardial adaptation to endurance exercise training in diabetic rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 252(6). R1073–R1081. 30 indexed citations
8.
Kopp, Stephen J., et al.. (1987). Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats.. Journal of Pharmacology and Experimental Therapeutics. 240(2). 529–534. 24 indexed citations
9.
Paulson, D. J., et al.. (1986). Impaired in Vivo Myocardial Reactivity to Norepinephrine in Diabetic Rats. Experimental Biology and Medicine. 183(2). 186–192. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026